13 11 20

Information and support

  • Get informed
  • Get support
  • Cut my risk
  • Get involved
  • Research
  • Compass GIST

    Acronym: 

    BLU-285-1304

    ACTRN/NCT /ethics: 

    Scientific title: 

    Summary of trial and patient characteristics

    Cancer Type Bowel and colon
    Trial Type Treatment
    Phase Phase III Tumour Stream Gastrointestinal Stromal Tumors
    Age Range 18 years and older Cancer Stage All stages
    Sex Both Anticipated Start Date
    Molecular Target Anticipated End Date
    Cancer Type Bowel and colon
    Trial Type Treatment
    Phase Phase III
    Age Range 18 years and older
    Sex Both
    Molecular Target
    Tumour Stream Gastrointestinal Stromal Tumors
    Cancer Stage All stages
    Anticipated Start Date
    Anticipated End Date

    Trial Summary

    An International, Multicenter, Open-label, Randomized, Phase 3 Study of Avapritinib vs Sunitinib in Patients with Genomically Selected Gastrointestinal Stromal Tumor (GIST)

    Lay Summary

    Sponsor / Cooperative group

    Participating Hospitals

    Hospital Clinical Trial Coordinator Email Phone Principal Investigator Recruitment Status
    Flinders Medical Centre Alex Scott-Hoy alex.scott-hoy@sa.gov.au 08 8204 4830 Amitesh Roy Not Yet Recruiting